Literature DB >> 19910638

Loss of endothelial Tie1 receptor impairs lymphatic vessel development-brief report.

Gabriela D'Amico1, Emilia Anne Korhonen, Marika Waltari, Pipsa Saharinen, Pirjo Laakkonen, Kari Alitalo.   

Abstract

OBJECTIVE: Studies of Tie1 gene-targeted embryos have demonstrated loss of blood vessel integrity, but the relevance of Tie1 in lymphatic vasculature development is unknown. We tested the hypothesis that the swelling observed in Tie1 mutant embryos is associated with lymphatic vascular defects. METHODS AND
RESULTS: We could extend the survival of the Tie1-deficient embryos in the ICR background, which allowed us to study their lymphatic vessel development. At embryonic day (E) 14.5, the Tie1(-/-) embryos had edema and hemorrhages and began to die. Immunohistochemical analysis revealed that they have abnormal lymph sacs. Tie1(-/-) mutants were swollen already at E12.5 without signs of hemorrhage. Their lymph sacs were abnormally patterned, suggesting that lymphatic malformations precede the blood vascular defects. We generated mice with a conditional Cre/loxP Tie1(neo) locus and found that the homozygous Tie1(neo/neo) hypomorphic embryos survived until E15.5 with lymphatic malformations resembling those seen in the Tie1(-/-) mutants.
CONCLUSIONS: Our data show that loss of Tie1 results in lymphatic vascular abnormalities that precede the blood vessel phenotype. These findings indicate that Tie1 is involved in lymphangiogenesis and suggest differential requirements for Tie1 signaling in the two vascular compartments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910638     DOI: 10.1161/ATVBAHA.109.196618

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  26 in total

1.  Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation.

Authors:  Emma J Gordon; Sujata Rao; Jeffrey W Pollard; Stephen L Nutt; Richard A Lang; Natasha L Harvey
Journal:  Development       Date:  2010-11       Impact factor: 6.868

Review 2.  Receptor tyrosine kinase-mediated angiogenesis.

Authors:  Michael Jeltsch; Veli-Matti Leppänen; Pipsa Saharinen; Kari Alitalo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

3.  Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice.

Authors:  Joseph M McClung; Timothy J McCord; Sehoon Keum; Soraya Johnson; Brian H Annex; Douglas A Marchuk; Christopher D Kontos
Journal:  Am J Pathol       Date:  2012-03-21       Impact factor: 4.307

Review 4.  Tie-1: A potential target for anti-angiogenesis therapy.

Authors:  Ping Yang; Na Chen; Jing-Hui Jia; Xue-Jiao Gao; Shi-Han Li; Jing Cai; Zehua Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

Review 5.  Development of the mammalian lymphatic vasculature.

Authors:  Ying Yang; Guillermo Oliver
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

Review 6.  Role of Tie1 in shear stress and atherosclerosis.

Authors:  Kel Vin Woo; H Scott Baldwin
Journal:  Trends Cardiovasc Med       Date:  2011-05       Impact factor: 6.677

7.  Mechanoinduction of lymph vessel expansion.

Authors:  Lara Planas-Paz; Boris Strilić; Axel Goedecke; Georg Breier; Reinhard Fässler; Eckhard Lammert
Journal:  EMBO J       Date:  2011-12-13       Impact factor: 11.598

8.  Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy.

Authors:  Gabriela D'Amico; Emilia A Korhonen; Andrey Anisimov; Georgia Zarkada; Tanja Holopainen; René Hägerling; Friedemann Kiefer; Lauri Eklund; Raija Sormunen; Harri Elamaa; Rolf A Brekken; Ralf H Adams; Gou Young Koh; Pipsa Saharinen; Kari Alitalo
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

9.  A role for BRG1 in the regulation of genes required for development of the lymphatic system.

Authors:  Ajeet Pratap Singh; Julie Foley; Arpit Tandon; Dhiral Phadke; H Karimi Kinyamu; Trevor K Archer
Journal:  Oncotarget       Date:  2017-07-04

10.  Targeting lymphatic vessel functions through tyrosine kinases.

Authors:  Steven P Williams; Tara Karnezis; Marc G Achen; Steven A Stacker
Journal:  J Angiogenes Res       Date:  2010-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.